Key Takeaways
- • ABP, one of the Netherlands' largest pension funds, co-invested in Nearfield Instruments as part of a $380 million Series D financing round that values the Rotterdam-based chip-testing company at $1.6 billion, achieving unicorn status.
- • The investment was made alongside Dutch venture capital firm Innovation Industries and reflects ABP's strategic pivot to direct capital toward high-potential Dutch and European technology companies.
- • Nearfield Instruments manufactures advanced atomic force microscopy technology that delivers picometer-level resolution imaging of semiconductor chips, enabling manufacturers to detect production defects with superior precision compared to conventional testing methods.
- • The company, founded a decade ago as a spin-off from TNO (a Delft-based research organization), will deploy capital to expand production capacity and meet surging semiconductor testing demand.
- • The co-investment aligns with ABP's broader mandate to strengthen European technological independence, reduce dependence on non-European suppliers, and foster innovation within the region while targeting attractive returns through private company exposure.
Summary
Nearfield Instruments specializes in proprietary atomic force microscopy technology that produces three-dimensional imaging of semiconductor chips with picometer-level resolution—a capability that significantly outperforms conventional defect detection methods used in chip manufacturing. This technological differentiation positions the company as a critical supplier within semiconductor production, where precision inspection has become essential as manufacturing processes advance.
The company's trajectory reflects the broader structural demand for advanced semiconductor testing infrastructure. Founded a decade ago as a research spin-off from TNO, Nearfield Instruments has achieved rapid growth, reaching a $1.4 billion valuation in June 2026 before climbing to $1.6 billion in the current financing round. The capital will be deployed to expand production capacity of its chip-testing machines to address rising global demand.
ABP's participation reflects its investment thesis combining attractive financial returns with strategic value creation. The pension fund has articulated a deliberate strategy to increase capital allocation toward high-potential Dutch and European companies, framed explicitly as supporting European technological sovereignty and reducing regional dependence on non-European competitors. This institutional co-investment model with specialized venture partners provides ABP with downside protection while maintaining exposure to high-growth semiconductor infrastructure assets.
The transaction demonstrates sustained institutional appetite for European deeptech companies addressing structural supply-chain challenges within semiconductor manufacturing—a sector experiencing sustained capital concentration among sophisticated investors targeting both financial returns and geopolitical resilience.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.